Schedule 13G ownership disclosure
TRAWS PHARMA INC
Common Stock, par value $.01 per share · CUSIP: 68232V884
Event date: 2025-09-12
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Squadron Master Fund LP
Shares: 372,374.00 · Class: 5.3%
- Squadron Capital Management LLC
Shares: 420,501.00 · Class: 6.0%
- Matthew Sesterhenn
Shares: 420,501.00 · Class: 6.0%
- William Blank
Shares: 420,501.00 · Class: 6.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002050709-25-000006
- Form type
- SCHEDULE 13G
- Filer
- Squadron Capital Management LLC
- CIK
- CIK 2050709
- Filed
- Sep 19, 2025
- Reporting period
- Sep 12, 2025
- Description
- Schedule 13G beneficial ownership